Yahoo
Frankfurt - Delayed Quote EUR

Kenvue Inc. (J4D.F)

17.38 +0.13 (+0.72%)
As of October 30 at 3:25:01 PM GMT+1. Market Open.
Chart Range Bar
Loading chart for J4D.F
  • Previous Close 17.25
  • Open 16.83
  • Bid --
  • Ask --
  • Day's Range 16.83 - 17.38
  • 52 Week Range 13.56 - 17.50
  • Volume 281
  • Avg. Volume 17
  • Market Cap (intraday) 33.4B
  • Beta (5Y Monthly) 0.40
  • PE Ratio (TTM) 22.87
  • EPS (TTM) 0.76
  • Earnings Date Oct 30, 2026
  • Forward Dividend & Yield 0.75 (4.30%)
  • Ex-Dividend Date Sep 21, 2026
  • 1y Target Est --

Kenvue Inc. operates as a consumer health company in the United States, rest of North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. It operates in three segments: Self Care, Skin Health and Beauty, and Essential Health. The company offers over-the-counter medicine for cough, cold and allergy, pain care, digestive health, smoking cessation, and eye care, as well as other naturally inspired and self-care products, digital diagnostics, and telemedicine; face and body care, hair, sun, and other care products; oral and baby care, women's health, wound care, and other essential health products; tampons; cosmetics; and vitamins and supplements. It sells its products under the Benadryl, Calpol, Motrin, Nicorette, Rhinocort, Tylenol, Zarbee's Naturals, and Zyrtec; Aveeno, Dr.Ci:Labo, Le Petit Marseillais, Lubriderm, Neutrogena, OGX, and Rogaine; BAND-AID, Carefree, Desitin, Johnson's, Listerine, o.b., and Stayfree; and ORSL, Clean & Clear, Versalie, Benylin, Daktarin, Imodium, Johnson's Baby, Johnson's Adult, Maui Moisture, Microlax, Motilium, Neosporin, Neostrata, Pepcid, Pulmicort, Regaine, Sudafed, and Visine/Vispring/Visclear brands. Kenvue Inc. was incorporated in 2022 and is headquartered in Summit, New Jersey.

www.kenvue.com

21,780

Full Time Employees

December 28

Fiscal Year Ends

Recent News

View More

Performance Overview

Trailing total returns as of 11/6/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

J4D.F
27.27%
S&P 500 (^GSPC)
7.76%

1-Year Return

J4D.F
37.47%
S&P 500 (^GSPC)
9.77%

3-Year Return

J4D.F
14.75%
S&P 500 (^GSPC)
68.96%

5-Year Return

J4D.F
26.48%
S&P 500 (^GSPC)
57.04%

Earnings Trends

View More

Earnings Per Share

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q3 FY26
Revenue 3.89B
Earnings 430M
Profit Margin 11.07%

Q4

FY25

Q1

FY26

Q2

FY26

Q3

FY26

0
1B
2B
3B
9.0%
10.0%
11.0%
12.0%

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    10.88%

  • Return on Assets (ttm)

    7.03%

  • Return on Equity (ttm)

    16.25%

  • Revenue (ttm)

    15.53B

  • Net Income Avi to Common (ttm)

    1.69B

  • Diluted EPS (ttm)

    0.76

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    1.04B

  • Total Debt/Equity (mrq)

    82.08%

  • Levered Free Cash Flow (ttm)

    2.77B

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: